Nevada Assembly Bill 234 aims to expand cancer screening accessibility for Medicaid beneficiaries
May 26, 2025 | 2025 Legislature NV, Nevada
This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »
The Assembly Committee on Ways and Means convened on May 26, 2025, to discuss Assembly Bill 234, aimed at enhancing access to cancer screenings for Nevada Medicaid beneficiaries. The bill seeks to expand colorectal cancer screening options, including at-home DNA stool testing, which aligns with the latest recommendations from the U.S. Preventative Services Task Force.
During the meeting, it was noted that the bill initially triggered a significant fiscal note from the Department of Health and Human Services, which would impact the state's general fund. In response to budget constraints, the Nevada Cancer Coalition proposed an amendment to remove the expansion of colorectal cancer screenings, thereby eliminating the fiscal note. Representatives from the Department confirmed that with this amendment, the fiscal note would be zero.
Support for the bill was voiced by various stakeholders, including Carrie Harrington, Executive Director of the Nevada Cancer Coalition, who emphasized the importance of ensuring that all cancer screenings are protected for Medicaid recipients. The Nevada Public Health Association and the Professional Firefighters of Nevada also expressed their support.
No opposition or neutral testimonies were presented during the meeting, indicating a consensus among attendees regarding the bill's importance. The committee concluded the session without further discussion, highlighting the bill's potential to improve cancer detection and treatment access for Nevadans.
During the meeting, it was noted that the bill initially triggered a significant fiscal note from the Department of Health and Human Services, which would impact the state's general fund. In response to budget constraints, the Nevada Cancer Coalition proposed an amendment to remove the expansion of colorectal cancer screenings, thereby eliminating the fiscal note. Representatives from the Department confirmed that with this amendment, the fiscal note would be zero.
Support for the bill was voiced by various stakeholders, including Carrie Harrington, Executive Director of the Nevada Cancer Coalition, who emphasized the importance of ensuring that all cancer screenings are protected for Medicaid recipients. The Nevada Public Health Association and the Professional Firefighters of Nevada also expressed their support.
No opposition or neutral testimonies were presented during the meeting, indicating a consensus among attendees regarding the bill's importance. The committee concluded the session without further discussion, highlighting the bill's potential to improve cancer detection and treatment access for Nevadans.
View full meeting
This article is based on a recent meeting—watch the full video and explore the complete transcript for deeper insights into the discussion.
View full meeting